激活转录因子6介导内质网应激时肠上皮细胞的炎症信号
本研究通过RNA干扰筛选(靶向7783个基因的23349条siRNA)鉴定ATF6信号通路的调控因子,发现CSNK2B和ACSL1为激活因子;在Caco-2细胞、小鼠肠类器官及克罗恩病患者回肠上皮细胞中证实ATF6介导内质网应激诱导的TNF等炎症因子表达,抑制ATF6通路可减轻小鼠肠道炎症。
要点
- 筛选鉴定出15个ATF6信号通路抑制因子和7个激活因子,包括CSNK2B和ACSL1。
- 克罗恩病患者回肠上皮细胞中ATF6、CSNK2B和HSPA5 mRNA水平高于对照。
- 抑制ACSL1或CSNK2B可减轻小鼠内质网应激诱导的肠道炎症和细胞死亡。
核心结论
- 克罗恩病患者回肠上皮细胞中活化ATF6水平升高,受CSNK2B和HSPA5调控。
- ATF6在内质网应激下增加TNF等炎症因子表达,抑制ATF6信号通路可能用于炎症性肠病治疗。
研究设计与样本
- 在HEK293细胞中进行RNA干扰筛选,使用23349条靶向7783个基因的siRNA和受ATF6依赖性ERSE启动子控制的荧光素酶报告基因。
- 在Caco-2细胞中转染siRNA或过表达组成性活化ATF6的质粒进行验证。
- 使用CRISPR介导敲除ATG16L1的Caco-2细胞研究ATF6对内质网应激的影响。
- 使用过表达组成性活化ATF6的小鼠、Atg16l1ΔIEC或Xbp1ΔIEC小鼠(均发生自发性回肠炎)及克罗恩病患者和健康对照的肠道类器官。
- 细胞和类器官用衣霉素诱导内质网应激和/或新鉴定ATF6激活蛋白的化学抑制剂处理,并通过实时聚合酶链反应和免疫印迹分析。
主要发现
- 鉴定并验证了15个ATF6信号通路抑制因子和7个激活因子,激活因子包括酪蛋白激酶2调节亚基(CSNK2B)和酰基辅酶A合成酶长链家族成员1(ACSL1)。
- 在Caco-2细胞中敲低或化学抑制CSNK2B和ACSL1降低了ATF6依赖性ERSE报告基因活性,减少了ATF6靶基因HSP90B1和HSPA5的转录,并降低了衣霉素刺激下的NF-κB报告基因激活。
- Atg16l1ΔIEC和Xbp1ΔIEC类器官显示ATF6及其靶基因表达增加;ACSL1或CSNK2B抑制剂阻止了衣霉素诱导的内质网应激下这些类器官中ATF6的活化,并降低了CXCL1和肿瘤坏死因子(TNF)表达。
- 给小鼠注射ACSL1或CSNK2B抑制剂显著减轻了衣霉素介导的肠道炎症、肠上皮细胞死亡以及Atg16l1ΔIEC小鼠中CXCL1和TNF的表达。
- 克罗恩病患者纯化的回肠上皮细胞中ATF6、CSNK2B和HSPA5信使RNA水平高于对照;活动性克罗恩病患者早期传代类器官显示活化ATF6蛋白水平升高,且ACSL1或CSNK2B抑制剂减少了包括TNF在内的ATF6靶基因转录。
临床怎么用
- 原文结论提出抑制ATF6信号通路的策略可能被开发用于炎症性肠病的治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Excess and unresolved endoplasmic reticulum (ER) stress in intestinal epithelial cells (IECs) promotes intestinal inflammation. Activating transcription factor 6 (ATF6) is one of the signaling mediators of ER stress. We studied the pathways that regulate ATF6 and its role for inflammation in IECs. METHODS: We performed an RNA interference screen, using 23,349 unique small interfering RNAs targeting 7783 genes and a luciferase reporter controlled by an ATF6-dependent ERSE (ER stress-response element) promoter, to identify proteins that activate or inhibit the ATF6 signaling pathway in HEK293 cells. To validate the screening results, intestinal epithelial cell lines (Caco-2 cells) were transfected with small interfering RNAs or with a plasmid overexpressing a constitutively active form of ATF6. Caco-2 cells with a CRISPR-mediated disruption of autophagy related 16 like 1 gene (ATG16L1) were used to study the effect of ATF6 on ER stress in autophagy-deficient cells. We also studied intestinal organoids derived from mice that overexpress constitutively active ATF6, from mice with deletion of the autophagy related 16 like 1 or X-Box binding protein 1 gene in IECs (Atg16l1ΔIEC or Xbp1ΔIEC, which both develop spontaneous ileitis), from patients with Crohn's disease (CD) and healthy individuals (controls). Cells and organoids were incubated with tunicamycin to induce ER stress and/or chemical inhibitors of newly identified activator proteins of ATF6 signaling, and analyzed by real-time polymerase chain reaction and immunoblots. Atg16l1ΔIEC and control (Atg16l1fl/fl) mice were given intraperitoneal injections of tunicamycin and were treated with chemical inhibitors of ATF6 activating proteins. RESULTS: We identified and validated 15 suppressors and 7 activators of the ATF6 signaling pathway; activators included the regulatory subunit of casein kinase 2 (CSNK2B) and acyl-CoA synthetase long chain family member 1 (ACSL1). Knockdown or chemical inhibition of CSNK2B and ACSL1 in Caco-2 cells reduced activity of the ATF6-dependent ERSE reporter gene, diminished transcription of the ATF6 target genes HSP90B1 and HSPA5 and reduced NF-κB reporter gene activation on tunicamycin stimulation. Atg16l1ΔIEC and or Xbp1ΔIEC organoids showed increased expression of ATF6 and its target genes. Inhibitors of ACSL1 or CSNK2B prevented activation of ATF6 and reduced CXCL1 and tumor necrosis factor (TNF) expression in these organoids on induction of ER stress with tunicamycin. Injection of mice with inhibitors of ACSL1 or CSNK2B significantly reduced tunicamycin-mediated intestinal inflammation and IEC death and expression of CXCL1 and TNF in Atg16l1ΔIEC mice. Purified ileal IECs from patients with CD had higher levels of ATF6, CSNK2B, and HSPA5 messenger RNAs than controls; early-passage organoids from patients with active CD show increased levels of activated ATF6 protein, incubation of these organoids with inhibitors of ACSL1 or CSNK2B reduced transcription of ATF6 target genes, including TNF. CONCLUSIONS: Ileal IECs from patients with CD have higher levels of activated ATF6, which is regulated by CSNK2B and HSPA5. ATF6 increases expression of TNF and other inflammatory cytokines in response to ER stress in these cells and in organoids from Atg16l1ΔIEC and Xbp1ΔIEC mice. Strategies to inhibit the ATF6 signaling pathway might be developed for treatment of inflammatory bowel diseases.
引用
- Stengel ST, Fazio A, Lipinski S, et al. Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress. Gastroenterology. 2020. PMID: 32673694. doi:10.1053/j.gastro.2020.06.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。